A detailed history of Clark Estates Inc transactions in Biogen Inc. stock. As of the latest transaction made, Clark Estates Inc holds 16,150 shares of BIIB stock, worth $2.41 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
16,150
Holding current value
$2.41 Million
% of portfolio
0.81%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$189.07 - $236.8 $3.05 Million - $3.82 Million
16,150 New
16,150 $3.13 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $1.81 Million - $2.33 Million
-8,100 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$259.0 - $414.71 $2.98 Million - $4.77 Million
-11,500 Reduced 58.67%
8,100 $2.81 Million
Q1 2021

May 14, 2021

BUY
$242.95 - $284.63 $2.6 Million - $3.05 Million
10,700 Added 120.22%
19,600 $5.48 Million
Q2 2020

Aug 05, 2020

SELL
$258.66 - $342.55 $1.19 Million - $1.58 Million
-4,600 Reduced 34.07%
8,900 $2.38 Million
Q2 2018

Aug 07, 2018

BUY
$257.52 - $306.91 $3.48 Million - $4.14 Million
13,500 New
13,500 $3.92 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Clark Estates Inc Portfolio

Follow Clark Estates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Clark Estates Inc with notifications on news.